If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLTG.L Regulatory News (BLTG)

  • There is currently no data for BLTG

Board Change

22 Sep 2015 07:02

RNS Number : 7407Z
Regenersis PLC
22 September 2015
 



22 September 2015

 

REGENERSIS PLC

("Regenersis")

 

DIRECTORS' DECLARATIONS

 

Regenersis Plc (AIM:RGS.L, "Regenersis", the "Group") is pleased to announce the following Board appointments from 1 October 2015:

 

Ian Donald Powell will join the main Board as Executive Director in the role of CEO of Aftermarket Services. Mr Powell, age 54, was previously Group Managing Director of Regenersis in the period 2011-2013, prior to that he has been CEO of Chapelthorpe plc, and Chairman Chairman/Chief Executive of several businesses where he held material equity stakes. In the last 5 years, Mr Powell has held the following Directorships:

Current directorships

Past directorships

Tangram Ventures Limited

Chapelthorpe plc

Tangram Trading Inc

 

 

Patrick J Clawson will join the main Board as Executive Director as CEO of Digital Security Software. Mr Clawson, aged 51, was previously Chairman/CEO of Lumension, a US endpoint security software business. In the last 5 years, Mr Clawson has held the following Directorships:

Current directorships

Past directorships

Blancco OY Limited

Cyberguard Inc

Xcaliber Technologies LLC

Lumension Inc

K is for Kids Foundation

 

Thomas Kevin Skelton will join the main Board as Non Executive Director. Mr Skelton, aged 54, is the current CEO of Surescripts, a market leading software business which enables over six billion annual e-prescriptions and other healthcare transactions in the USA. Until recently, he had been a non-executive director of Micro Focus International Plc since 2006. Mr Skelton has no current shareholding or share option or incentive plan awards in Regenersis.

Current directorships

Past directorships

Surescripts LLC

Microfocus International Plc

 

Regenersis confirms that there are no further disclosures required in accordance with paragraph (g) of Schedule Two, AIM Rules for Companies.

 

Enquiries:

 

Regenersis Plc +44 (0) 20 3657 7000

Matthew Peacock, Executive Chairman

Jog Dhody, Chief Financial Officer

 

Peel Hunt LLP (Nomad and Joint Broker) +44 (0) 20 7418 8900

Richard Kauffer

Edward Fox

 

Panmure Gordon (UK) Limited (Joint Broker) +44 (0) 20 7886 2500

Charles Leigh Pemberton

Tulchan Communications +44 (0) 20 7353 4200

Tom Murray

Victoria Huxster

 

Regenersis provides a suite of product life cycle support services designed to help companies and their customers successfully deploy, protect, sustain, retire and re-use digital technology.

 

www.regenersis.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADBGDCSDDBGUB
Date   Source Headline
4th Aug 20239:46 amGNWForm 8.3 - Blancco Technology Group Plc
3rd Aug 20235:02 pmRNSForm 8.3 - Blancco
3rd Aug 20234:50 pmRNSForm 8.3 - Blancco Technology Group Plc
3rd Aug 20233:41 pmRNSNotification of Major Holdings
3rd Aug 20233:21 pmEQSForm 8.3 - Apex Fundrock Limited :
3rd Aug 20232:37 pmRNSForm 8.3 - Blancco Technology Group plc
3rd Aug 20232:24 pmRNSForm 8.3 - Blancco Technology Group PLC
3rd Aug 202312:57 pmRNSForm 8.3 - Blancco Technology Group PLC
3rd Aug 202312:27 pmRNSForm 8.3 - Blancco Technology Group PLC
3rd Aug 202312:04 pmRNSForm 8.3 - Blancco Technology Group Plc
3rd Aug 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
3rd Aug 202310:54 amRNSForm 8.3 - Blancco Technology Group Plc
3rd Aug 202310:49 amRNSForm 8.3 - Blancco Technology Group plc
3rd Aug 202310:23 amGNWForm 8.3 - [BLANCCO TECHNOLOGY GROUP PLC - Opening Declaration - 02 08 2023] - (CGAML)
3rd Aug 20239:31 amGNWForm 8.3 - Blancco Technology Group Plc
3rd Aug 20239:14 amRNSForm 8.3 - Blancco Technology Group plc
2nd Aug 20233:41 pmRNSForm 8.3 - Blancco Technology Group PLC
2nd Aug 20237:00 amRNSRecommended Cash Offer
24th Jul 20237:00 amRNSAppointment of Nominated Adviser and Broker
3rd Jul 20237:00 amRNSTrading Update
26th Jun 20237:00 amRNSCarbon Neutral Status Maintained
20th Apr 20235:17 pmRNSNotification of Major Holdings
21st Feb 20237:00 amRNSInterim Results
3rd Feb 20239:53 amRNSInvestor Presentation
3rd Feb 20239:06 amRNSNotice of Results
1st Feb 20235:51 pmRNSNotification of Major Holdings
31st Jan 20237:00 amRNSAppointment of Nominated Adviser and Joint Broker
27th Jan 202310:47 amRNSNotification of Major Holdings
11th Jan 20237:00 amRNSBlancco Awarded "AA" Rating by MSCI ESG
13th Dec 20223:00 pmRNSResult of AGM
27th Oct 20222:33 pmRNSPosting of Annual Report and Notice of AGM
19th Oct 20227:00 amRNSPublication of ESG Report
13th Oct 202210:19 amRNSSHARE ALLOTMENT AND TOTAL VOTING RIGHTS
11th Oct 202210:06 amRNSDirectors’ Dealing
10th Oct 202212:32 pmRNSDirectors' Dealing
30th Sep 20224:15 pmRNSDirectors' Dealing
28th Sep 20227:00 amRNSFinal Results
23rd Sep 20229:16 amRNSNotification of Major Holdings
9th Sep 20222:54 pmRNSInvestor Presentation
19th Aug 20227:00 amRNSNotice of Results
28th Jun 20227:00 amRNSCarbon Neutral Status Achieved
8th Jun 20227:00 amRNSAcquisition
3rd Mar 20227:00 amRNSMembership of Global Sustainability Initiative
22nd Feb 20227:00 amRNSInterim Results
28th Jan 202210:30 amRNSInvestor Presentation
18th Jan 20227:00 amRNSTrading Update
15th Dec 20214:42 pmRNSDirectors' Dealing
15th Dec 20214:42 pmRNSDirectors' Dealing
14th Dec 20211:22 pmRNSResult of AGM
13th Dec 20214:46 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.